Exercise, specifically resistance training, keeps that metabolic engine running throughout your treatment period
Typically, GLP-1 receptor agonists are recommended for individuals with a BMI of 30 kg/m or higher, classified as obesity, or for those with a BMI of at least 27 kg/m who also have obesity-related health conditions such as hypertension, type 2 diabetes , or high cholesterol
The main pattern is a reduction in overall food purchases. Unlike previous studies that relied on self-reported eating habits, the new analysis draws on purchase data collected by Numerator, a market research firm that tracks grocery and restaurant transactions for a nationally representative panel of about 150,000 households
Sama warto BMI nie przesdza o recepcie decyzj podejmuje lekarz po ocenie stanu zdrowia, chorb wspistniejcych i przyjmowanych lekw
Can my dose be adjusted without a price increase